Generated Narrative: Composition composition-en-b6ced64d25ea2c8da6c6099386f14db1 Language: en Profile: Composition (ePI) identifier: https://spor.ema.europa.eu/rmswi//EU/1/18/1326/001 status: Final type: Package Leaflet category: Raw date: 2023-04-22 15:15:46+0000 author: Organization Seqirus Netherlands B.V. title: TEST PURPOSES ONLY - Flucelvax Tetra - suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, prepared in cell cultures) Attesters - Mode Time * Official 2023-04-22 15:15:46+0000
TEST PURPOSES ONLY - Flucelvax Tetra - suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, prepared in cell cultures)
unavailable
Package leaflet: Information for the user
Read all of this leaflet carefully before you receive this medicine because it contains important information for you. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor, pharmacist or nurse. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4.
What is in this leaflet What Flucelvax Tetra is and what it is used for What you need to know before you receive Flucelvax Tetra How Flucelvax Tetra is given Possible side effects How to store Flucelvax Tetra Contents of the pack and other information
1. What Flucelvax is and what it is used for
Flucelvax Tetra is a vaccine against flu (influenza). Flucelvax Tetra is prepared in cell cultures, and, therefore, is egg-free. When a person is given the vaccine, the immune system (the body’s natural defence system) will produce its own protection against the influenza virus. None of the ingredients in the vaccine can cause flu. Flucelvax Tetra is used to prevent flu in adults and children from 2 years of age. The vaccine targets four strains of influenza virus following the recommendations by the World Health Organisation for the 2022/2023 SEASON.
2. What you need to know before you take Flucelvax
You should not receive Flucelvax Tetra: If you are allergic to: the active ingredients or any of the other ingredients of this medicine (listed in section 6) beta-propiolactone, cetyltrimethylammonium bromide, or polysorbate 80, which are trace residues from the manufacturing process. Warnings and precautions Talk to your doctor, pharmacist or nurse before receiving Flucelvax Tetra. BEFORE receiving the vaccine. Your doctor or nurse will make sure that appropriate medical treatment and supervision is readily available in case of a rare anaphylactic reaction (a very severe allergic reaction with symptoms such as difficulty in breathing, dizziness, a weak and rapid pulse and skin rash) following the administration. This reaction may occur with Flucelvax Tetra as with all vaccines that are injected. You should tell your doctor if you have an acute illness associated with fever. Your doctor may decide to delay your vaccination until your fever is gone. You should tell your doctor if your immune system is impaired, or if you are undergoing treatment which affects the immune system, e.g. with medicine against cancer (chemotherapy) or corticosteroid medicines (see section “Other medicines and Flucelvax Tetra”). You should tell your doctor if you have a bleeding problem or bruise easily. Fainting can occur following, or even before, any needle injection, therefore tell the doctor or nurse if you fainted with a previous injection. As with all vaccines, Flucelvax Tetra may not fully protect all persons who are vaccinated. Other medicines and Flucelvax Tetra Tell your doctor or nurse if you are using, have recently used or might use any other medicines, including medicines obtained without a prescription or if you have recently received any other vaccine. Flucelvax Tetra may be given at the same time as other vaccines. Pregnancy and breast-feeding Pregnancy: Tell your doctor if you are pregnant, think you may be pregnant or are planning to have a baby. Influenza vaccines may be given in any trimester of pregnancy. Breast-feeding: Use of Flucelvax Tetra during breast-feeding has not been studied. Flucelvax Tetra may be given during breast-feeding. Driving and using machines Flucelvax Tetra has no or negligible effect on your ability to drive and use machines. Flucelvax Tetra contains sodium chloride and potassium chloride This vaccine contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially ‘sodium free’. This vaccine contains potassium, less than 1 mmol (39 mg) per dose, i.e. essentially ‘potassium free’
Flucelvax Tetra is given to you by your doctor or nurse as an injection into the muscle at the top of the upper arm (deltoid muscle). Adults and children from 2 years of age: One dose of 0.5 ml If your child is younger than 9 years of age and has not been previously vaccinated against flu, a second dose should be given after at least 4 weeks.
Like all medicines, this medicine can cause side effects, although not everybody gets them. The following side effects have been reported during clinical trials and during general use: Very serious side effects Tell your doctor immediately or go to the casualty department at your nearest hospital if you experience the following side effect – you may need urgent medical attention or hospitalisation: Difficulty in breathing, dizziness, a weak and rapid pulse and skin rash which are symptoms of an anaphylactic reaction (a very severe allergic reaction) Serious side effects Tell your doctor immediately if you experience any of the following side effects – you may need medical attention: You feel weak, you have difficulty moving around or you experience numbness or tingling in your limbs. These can be symptoms of Guillain-Barré syndrome (GBS), an autoimmune disease caused by your body’s own immune system. Extensive swelling of injected limb Mild side effects Very common (may affect more than 1 in 10 people): Injection site pain, bruising, reddening and hardening or swelling at the site of the injection Headache Muscle pain Tiredness Loss of appetite Irritability (only reported in children from 2 to < 6 years) Sleepiness (only reported in children 2 to < 6 years) Hardening or swelling at the site of the injection, headache, muscle pain, and tiredness were common in the elderly. Bruising at the site of the injection was common in adults, eldery and children 9 to < 18 years. Headache was common in the elderly. Loss of appetite was common in adults, eldery and children 9 to < 18 years. Common (may affect up to 1 in 10 people): Nausea, vomiting, diarrhoea Joint pain Shivering Change in eating habits (only reported in children from 2 to < 6 years) Fever (> 38°C) Vomiting was uncommon in the elderly. Fever was uncommon in adults and the elderly. Not known (frequency cannot be estimated from the available data): Numbness and tingling sensation (paraesthesia) Generalised skin reactions including itching, bumps on the skin (pruritis, urticaria) or non-specific rash Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V.* By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this vaccine out of the sight and reach of children. Store in a refrigerator (2 °C to 8 °C). Do not freeze. Keep the pre-filled syringe in the outer carton in order to protect from light. Do not use this vaccine after the expiry date which is stated on the label and carton after EXP. The expiry date refers to the last day of that month. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
6. Contents of the pack and other information
What Flucelvax Tetra contains The active substances are influenza virus surface antigens (haemagglutinin and neuraminidase), inactivated, of the following strains*: A/Wisconsin/588/2019 (H1N1)pdm09-like strain (A/Delaware/55/2019 CVR-45) 15 micrograms HA** A/Darwin/6/2021 (H3N2)-like strain (A/Darwin/11/2021, wild type) 15 micrograms HA** B/Austria/1359417/2021-like strain (B/Singapore/WUH4618/2021, wild type) 15 micrograms HA** B/Phuket/3073/2013-like strain (B/Singapore/INFTT-16-0610/2016, wild type) 15 micrograms HA** per 0.5 ml dose .............................................. * propagated in Madin Darby Canine Kidney (MDCK) cells (this is the special cell culture in which the influenza virus is grown); ** haemagglutinin This vaccine complies with the World Health Organisation (WHO) recommendation (northern hemisphere) and EU recommendation for the 2022/2023 SEASON. The other ingredients are: sodium chloride, potassium chloride, magnesium chloride hexahydrate, disodium phosphate dihydrate, potassium dihydrogen phosphate and water for injections. What Flucelvax Tetra looks like and contents of the pack Flucelvax Tetra is a suspension for injection in a pre-filled syringe (ready to use syringe). Flucelvax Tetra is a clear to slightly opalescent suspension.A single syringe contains 0.5 ml of suspension for injection.Flucelvax Tetra is available in packs containing 1 pre-filled syringe with or without needle or 10 pre- filled syringes with or without needles. Not all pack sizes may be marketed.
Generated Narrative: Ingredient ingredient-for-2e8cb2387c664fb619f6b8914767d38f Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/9V4SVN4JQV (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#EU/1/18/1326/001 (use: official, ); status = active; manufacturedDoseForm = suspension for injection in pre-filled syringe; unitOfPresentation = Syringe MedicinalProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#EU/1/18/1326/001,https://www.who-umc.org/phpid#0xF79CABF272B6A7EEF104DDDA44E82717; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#xx; status = active; administrableDoseForm = suspension for injection in pre-filled syringe; unitOfPresentation = Syringe role: active substance Codes - Concept * INFLUENZA A VIRUS A/Delaware/55/2019 CVR-45 (H1N1) WHOLE Strengths - Presentation[x] Basis * 15 ug (Details: UCUM codeug = 'ug') active ingredient - basis of strength
INFLUENZA A VIRUS A/Delaware/55/2019 CVR-45 (H1N1) WHOLE
Generated Narrative: Ingredient ingredient-for-flucelvax-influenzaavirusadarwin112021h3n2whole Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/JS7E5ZZ3AC (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#EU/1/18/1326/001 (use: official, ); status = active; manufacturedDoseForm = suspension for injection in pre-filled syringe; unitOfPresentation = Syringe MedicinalProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#EU/1/18/1326/001,https://www.who-umc.org/phpid#0xF79CABF272B6A7EEF104DDDA44E82717; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#xx; status = active; administrableDoseForm = suspension for injection in pre-filled syringe; unitOfPresentation = Syringe role: active substance Codes - Concept * INFLUENZA A VIRUS A/Darwin/11/2021 (H3N2) WHOLE Strengths - Presentation[x] Basis * 15 ug (Details: UCUM codeug = 'ug') active ingredient - basis of strength
INFLUENZA A VIRUS A/Darwin/11/2021 (H3N2) WHOLE
Generated Narrative: Ingredient ingredient-for-f4e520e2974f4acb8abe26b607ea5a46 Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/BFA4LSE5QQ (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#EU/1/18/1326/001 (use: official, ); status = active; manufacturedDoseForm = suspension for injection in pre-filled syringe; unitOfPresentation = Syringe MedicinalProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#EU/1/18/1326/001,https://www.who-umc.org/phpid#0xF79CABF272B6A7EEF104DDDA44E82717; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#xx; status = active; administrableDoseForm = suspension for injection in pre-filled syringe; unitOfPresentation = Syringe role: active substance Codes - Concept * INFLUENZA B VIRUS B/Singapore/WUH4618/2021 WHOLE Strengths - Presentation[x] Basis * 15 ug (Details: UCUM codeug = 'ug') active ingredient - basis of strength
INFLUENZA B VIRUS B/Singapore/WUH4618/2021 WHOLE
Generated Narrative: Ingredient ingredient-for-2c0c197a41a706fb2549601e635da1f3 Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/B3EV5T8SUF (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#EU/1/18/1326/001 (use: official, ); status = active; manufacturedDoseForm = suspension for injection in pre-filled syringe; unitOfPresentation = Syringe MedicinalProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#EU/1/18/1326/001,https://www.who-umc.org/phpid#0xF79CABF272B6A7EEF104DDDA44E82717; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#xx; status = active; administrableDoseForm = suspension for injection in pre-filled syringe; unitOfPresentation = Syringe role: active substance Codes - Concept * INFLUENZA B VIRUS B/SINGAPORE/INFTT-16-0610/2016 WHOLE Strengths - Presentation[x] Basis * 15 ug (Details: UCUM codeug = 'ug') active ingredient - basis of strength
INFLUENZA B VIRUS B/SINGAPORE/INFTT-16-0610/2016 WHOLE
Generated Narrative: Ingredient ingredient-for-flucelvax-sodiumchloride Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/451W47IQ8X (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#EU/1/18/1326/001 (use: official, ); status = active; manufacturedDoseForm = suspension for injection in pre-filled syringe; unitOfPresentation = Syringe MedicinalProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#EU/1/18/1326/001,https://www.who-umc.org/phpid#0xF79CABF272B6A7EEF104DDDA44E82717; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#xx; status = active; administrableDoseForm = suspension for injection in pre-filled syringe; unitOfPresentation = Syringe role: Excipient substance Codes - Concept * Sodium chloride
Generated Narrative: Ingredient ingredient-for-flucelvax-potassiumchloride Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/660YQ98I10 (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#EU/1/18/1326/001 (use: official, ); status = active; manufacturedDoseForm = suspension for injection in pre-filled syringe; unitOfPresentation = Syringe MedicinalProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#EU/1/18/1326/001,https://www.who-umc.org/phpid#0xF79CABF272B6A7EEF104DDDA44E82717; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#xx; status = active; administrableDoseForm = suspension for injection in pre-filled syringe; unitOfPresentation = Syringe role: Excipient substance Codes - Concept * Potassium chloride
Generated Narrative: Ingredient ingredient-for-flucelvax-magnesiumchloride Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/02F3473H9O (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#EU/1/18/1326/001 (use: official, ); status = active; manufacturedDoseForm = suspension for injection in pre-filled syringe; unitOfPresentation = Syringe MedicinalProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#EU/1/18/1326/001,https://www.who-umc.org/phpid#0xF79CABF272B6A7EEF104DDDA44E82717; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#xx; status = active; administrableDoseForm = suspension for injection in pre-filled syringe; unitOfPresentation = Syringe role: Excipient substance Codes - Concept * MAGNESIUM CHLORIDE
Generated Narrative: Ingredient ingredient-for-flucelvax-sodiumphosphatedibasicdihydrate Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/94255I6E2T (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#EU/1/18/1326/001 (use: official, ); status = active; manufacturedDoseForm = suspension for injection in pre-filled syringe; unitOfPresentation = Syringe MedicinalProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#EU/1/18/1326/001,https://www.who-umc.org/phpid#0xF79CABF272B6A7EEF104DDDA44E82717; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#xx; status = active; administrableDoseForm = suspension for injection in pre-filled syringe; unitOfPresentation = Syringe role: Excipient substance Codes - Concept * SODIUM PHOSPHATE, DIBASIC, DIHYDRATE
Generated Narrative: Ingredient ingredient-for-flucelvax-potassiumdihydrogenphosphate Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/4J9FJ0HL51 (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#EU/1/18/1326/001 (use: official, ); status = active; manufacturedDoseForm = suspension for injection in pre-filled syringe; unitOfPresentation = Syringe MedicinalProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#EU/1/18/1326/001,https://www.who-umc.org/phpid#0xF79CABF272B6A7EEF104DDDA44E82717; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#xx; status = active; administrableDoseForm = suspension for injection in pre-filled syringe; unitOfPresentation = Syringe role: Excipient substance Codes - Concept * Potassium dihydrogen phosphate
Generated Narrative: Ingredient ingredient-for-flucelvax-waterforinjections Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/059QF0KO0R (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#EU/1/18/1326/001 (use: official, ); status = active; manufacturedDoseForm = suspension for injection in pre-filled syringe; unitOfPresentation = Syringe MedicinalProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#EU/1/18/1326/001,https://www.who-umc.org/phpid#0xF79CABF272B6A7EEF104DDDA44E82717; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#xx; status = active; administrableDoseForm = suspension for injection in pre-filled syringe; unitOfPresentation = Syringe role: Excipient substance Codes - Concept * Water for injections
Generated Narrative: SubstanceDefinition substance-influenzaavirusadelaware552019cvr45h1n1whole Profile: SubstanceDefinition (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta//9V4SVN4JQV (use: official, ) version: 1.0 status: Active manufacturer: Organization Seqirus Netherlands B.V.
Generated Narrative: SubstanceDefinition substance-influenzaavirusadarwin112021h3n2whole Profile: SubstanceDefinition (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta//JS7E5ZZ3AC (use: official, ) status: Active manufacturer: Organization Seqirus Netherlands B.V.
Generated Narrative: SubstanceDefinition substance-influenzabvirusbsingaporewuh46182021whole Profile: SubstanceDefinition (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta//BFA4LSE5QQ (use: official, ) status: Active manufacturer: Organization Seqirus Netherlands B.V.
Generated Narrative: SubstanceDefinition substance-influenzabvirusbsingaporeinftt1606102016whole Profile: SubstanceDefinition (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta//B3EV5T8SUF (use: official, ) status: Active manufacturer: Organization Seqirus Netherlands B.V.
Generated Narrative: AdministrableProductDefinition ap-04c9bd6fb89d38b2d83eced2460c4dc1 Profile: AdministrableProductDefinition (ePI) identifier: https://spor.ema.europa.eu/pmswi/xx status: Active formOf: MedicinalProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#EU/1/18/1326/001,https://www.who-umc.org/phpid#0xF79CABF272B6A7EEF104DDDA44E82717; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription administrableDoseForm: suspension for injection in pre-filled syringe unitOfPresentation: Syringe producedFrom: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#EU/1/18/1326/001 (use: official, ); status = active; manufacturedDoseForm = suspension for injection in pre-filled syringe; unitOfPresentation = Syringe routeOfAdministration code: Subcutaneous use TargetSpecies - Code * Human
suspension for injection in pre-filled syringe
Generated Narrative: RegulatedAuthorization authorization04c9bd6fb89d38b2d83eced2460c4dc10 Profile: RegulatedAuthorization (ePI) identifier: https://spor.ema.europa.eu/pmswi/EU/1/18/1326/001 (use: official, ) subject: MedicinalProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#EU/1/18/1326/001,https://www.who-umc.org/phpid#0xF79CABF272B6A7EEF104DDDA44E82717; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription type: Marketing Authorisation status: Active statusDate: 2019-01-01 holder: Organization Seqirus Netherlands B.V.
Generated Narrative: Organization mah-45fe50eae508b5755dd140ab2093eb5e Profile: Organization (ePI) identifier: https://spor.ema.europa.eu/omswi/ORG-100013715 (use: official, ) active: true type: Marketing authorisation holder name: Seqirus Netherlands B.V. Contacts - Address * Paasheuvelweg 28 1105BJ Amsterdam Netherlands(work)
Paasheuvelweg 28 1105BJ Amsterdam Netherlands
Generated Narrative: PackagedProductDefinition ppd-a854b6fee6a8536c78c604a4b9f6c395 Profile: PackagedProductDefinition (ePI) name: Flucelvax Tetra - suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, prepared in cell cultures) 1 type: 100000155527 packageFor: MedicinalProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#EU/1/18/1326/001,https://www.who-umc.org/phpid#0xF79CABF272B6A7EEF104DDDA44E82717; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription status: Active statusDate: 2019-01-01 containedItemQuantity: 15 ug (Details: UCUM codeug = 'ug') copackagedIndicator: true packaging type: Box quantity: 1 material: Cardboard packaging identifier: https://spor.ema.europa.eu/pmswi/xxxx type: 100000073498 quantity: 1 material: Cardboard containedItem Items - Reference * ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#EU/1/18/1326/001 (use: official, ); status = active; manufacturedDoseForm = suspension for injection in pre-filled syringe; unitOfPresentation = Syringe
Flucelvax Tetra - suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, prepared in cell cultures) 1
Generated Narrative: MedicinalProductDefinition mpb6ced64d25ea2c8da6c6099386f14db1 Profile: MedicinalProductDefinition (ePI) identifier: https://spor.ema.europa.eu/pmswi/EU/1/18/1326/001, https://www.who-umc.org/phpid/0xF79CABF272B6A7EEF104DDDA44E82717 type: Medicinal Product domain: Human use status: active legalStatusOfSupply: Medicinal product subject to medical prescription name productName: Flucelvax Tetra - suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, prepared in cell cultures) type: Full name part part: Flucelvax Tetra type: Invented name part part part: Influenza vaccine (surface antigen, inactivated, prepared in cell cultures) type: Scientific name part part part: 15 ug type: Strength part part part: Solution for injection type: Pharmaceutical dose form part Usages - Country Jurisdiction Language * Spain Spain English
Medicinal product subject to medical prescription
Flucelvax Tetra - suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, prepared in cell cultures)
Influenza vaccine (surface antigen, inactivated, prepared in cell cultures)
Generated Narrative: ManufacturedItemDefinition mid-04c9bd6fb89d38b2d83eced2460c4dc1 Profile: ManufacturedItemDefinition (ePI) identifier: https://spor.ema.europa.eu/pmswi/EU/1/18/1326/001 (use: official, ) status: Active manufacturedDoseForm: suspension for injection in pre-filled syringe unitOfPresentation: Syringe